The Effect of Epigallocatechin Galleate, Black Tea Extract and Sarcophytol A on DNA Strand Breakage Induced by Tobacco-Specific Nitrosamines and Stimulated Human Phagocytes
Issue: Vol.4, No.2 - April 2005
Article Type: Manuscript
The tobacco-specific nitrosamines (TSNAs) are metabolites of nicotine and are major carcinogens in cigarette smoke. Chronic inflammation may promote the carcinogenic effect of these nitrosamines through the generation of oxygen radicals as evidenced by an increase in DNA strand breakage in cultured human lung cells treated with stimulated human phagocytes and TSNAs. Sarcophytol A(SaA), a simple monohydroxycem-bratetraene isolated from marine soft coral - epigallocatechin galleate (EGCG), one of the main constituents of green tea, and black tea extract (BTE) all inhibit tumor promotion. To evaluate their effect on TSNA-induced genetic damage, cultured human lung cells were pretreated with SaA, EGCG, or BTE, and then exposed to the TSNA -4 - (N-methyl-N-nitrosamino )-1-(3pyridyl)-1- butanone (NNK) and stimulated human phagocytes and then assayed for single strand DNA breaks. SaA, EGCG and BTE provided significant protection against the induction of genetic damage in these cells and proved useful in the chemo-prevention of tobacco-induced carcinogenesis.
Also In This Issue
- Editorial: Ethical Principles in Cancer Care
- Profile - Prof. Simon Gandevia
- Effect of an Information Leaflet on the Improvement of Oral Cancer Knowledge Among the General and the High Risk Population
- Advantages of Applying a Multifactoral Approach to Estimating the Contribution of Indoor Radon to Lung Cancer Risk
- Beyond PSA: New Serum Markers for Improved Diagnosis and Management of Prostate Cancer
- A Combination of Ondansetron, Metoclopramide, Dexamethazone and Lorazepam for the Prevention of Irinotecan Induced Nausea and Vomiting
- Self as Female: Womens\' Experiences Following Treatment for Breast Cancer or Uterus Cancer
- Progress in Radiation Therapy for Esophageal Cancer
- Basic Principles of Cancer Care: From the Cancer Patients\' Perspective